Bridgeway Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-91,144
| Closed | -$643K | – | 1382 |
|
|
2020
Q1 | $643K | Hold |
91,144
| – | – | 0.01% | 677 |
|
|
2019
Q4 | $643K | Hold |
91,144
| – | – | 0.01% | 870 |
|
|
2019
Q3 | $1.1M | Hold |
91,144
| – | – | 0.02% | 700 |
|
|
2019
Q2 | $1.1M | Sell |
91,144
-30,256
| -25% | -$366K | 0.01% | 705 |
|
|
2019
Q1 | $1.53M | Buy |
121,400
+35,800
| +42% | +$450K | 0.02% | 619 |
|
|
2018
Q4 | $576K | Hold |
85,600
| – | – | 0.01% | 952 |
|
|
2018
Q3 | $881K | Buy |
85,600
+35,000
| +69% | +$360K | 0.01% | 935 |
|
|
2018
Q2 | $340K | Buy |
50,600
+11,600
| +30% | +$77.9K | ﹤0.01% | 1228 |
|
|
2018
Q1 | $335K | Hold |
39,000
| – | – | ﹤0.01% | 1179 |
|
|
2017
Q4 | $811K | Hold |
39,000
| – | – | 0.01% | 925 |
|
|
2017
Q3 | $689K | Buy |
+39,000
| New | +$689K | 0.01% | 986 |
|